Publication:
A central link between angiotensinergic and cholinergic systems; role of vasopressin

dc.contributor.buuauthorİşbil, Büyükcoşkun Naciye
dc.contributor.buuauthorGüleç, Güliz Uyar
dc.contributor.buuauthorÖzlük, Kasım
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFizyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0003-0863-1547
dc.contributor.researcheridAAH-1692-2021
dc.contributor.researcheridC-5730-2015
dc.contributor.scopusid6603128152
dc.contributor.scopusid6602752303
dc.contributor.scopusid6602676331
dc.date.accessioned2022-01-10T05:35:32Z
dc.date.available2022-01-10T05:35:32Z
dc.date.issued2001-09
dc.description.abstractParticipation of central cholinergic system in the effects of intracerebroventricular (i.c.v.) injection of angiotensin II (Ana II) on blood pressure and heart rate was studied in conscious, freely moving rats, Ang II dose-dependently increased blood pressure and decreased heart rate. Both atropine and mecamylamine (i.c.v.) pretreatments prevented the cardiovascular effects of Ana II. Pretreatment with a vasopressin V-1 antagonist also prevented the cardiovascular responses to Ang II. Our data suggest that the central pressor effect of Ang II is mediated in part by central acetylcholine via both muscarinic and nicotinic receptors, and vasopressin participates in this effect through V-1 receptors.
dc.identifier.citationİşbil, B. N. vd. (2001). "A central link between angiotensinergic and cholinergic systems; role of vasopressin". Peptides, 22(9), 1415-1420.
dc.identifier.endpage1420
dc.identifier.issn0196-9781
dc.identifier.issue9
dc.identifier.pubmed11514022
dc.identifier.scopus2-s2.0-0034888525
dc.identifier.startpage1415
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0196978101004788
dc.identifier.urihttps://doi.org/10.1016/S0196-9781(01)00478-8
dc.identifier.urihttp://hdl.handle.net/11452/23941
dc.identifier.volume22
dc.identifier.wos000170561200008
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalPeptides
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCholinergic system
dc.subjectAng II
dc.subjectBlood pressure
dc.subjectHeart rate
dc.subjectIntracerebroventricular
dc.subjectV1 antagonist
dc.subjectPressor
dc.subjectResponses
dc.subjectRelease
dc.subjectInjection
dc.subjectCarbachol
dc.subjectDrinking
dc.subjectBrain
dc.subjectBiochemistry & molecular biology
dc.subjectEndocrinology & metabolism
dc.subjectPharmacology & pharmacy
dc.subject.emtreeAcetylcholine
dc.subject.emtreeArticle
dc.subject.emtreeAnimal experiment
dc.subject.emtreeCardiovascular effect
dc.subject.emtreeCardiovascular response
dc.subject.emtreeCholinergic system
dc.subject.emtreeControlled study
dc.subject.emtreeBlood pressure
dc.subject.emtreeDose response
dc.subject.emtreeHeart rate
dc.subject.emtreeMale
dc.subject.emtreeNonhuman
dc.subject.emtreePriority journal
dc.subject.emtreeRat
dc.subject.emtreeAngiotensin
dc.subject.emtreeAtropine
dc.subject.emtreeMecamylamine
dc.subject.emtreeMuscarinic receptor
dc.subject.emtreeNicotinic receptor
dc.subject.emtreeVasopressin
dc.subject.emtreeVasopressin receptor antagonist
dc.subject.emtreeVasopressin V1 receptor
dc.subject.meshAngiotensin II
dc.subject.meshAnimals
dc.subject.meshSympathetic nervous system
dc.subject.meshBrain
dc.subject.meshReceptors, vasopressin
dc.subject.meshAtropine
dc.subject.meshBlood pressure
dc.subject.meshConsciousness
dc.subject.meshDose-response relationship, drug
dc.subject.meshDrug Interactions
dc.subject.meshTime factors
dc.subject.meshHeart rate
dc.subject.meshInjections, intraventricular
dc.subject.meshInjections, intra-arterial
dc.subject.meshMale
dc.subject.meshMecamylamine
dc.subject.meshMuscarinic antagonists
dc.subject.meshNicotinic antagonists
dc.subject.meshRats
dc.subject.meshRats, sprague-dawley
dc.subject.meshReceptors, mmuscarinic
dc.subject.meshReceptors, nicotinic
dc.subject.meshVasopressins
dc.subject.scopusPregnanolone; Orexins; Scotophase
dc.subject.wosBiochemistry & molecular biology
dc.subject.wosEndocrinology & metabolism
dc.subject.wosPharmacology & pharmacy
dc.titleA central link between angiotensinergic and cholinergic systems; role of vasopressin
dc.typeArticle
dc.wos.quartileQ2 (Biochemistry & molecular biology)
dc.wos.quartileQ2 (Pharmacology & pharmacy)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Fizyoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: